| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Proteomics | 50 | 2024 | 3810 | 5.110 |
Why?
|
| Metabolomics | 46 | 2024 | 1626 | 4.670 |
Why?
|
| Metabolome | 31 | 2024 | 976 | 3.620 |
Why?
|
| Blood Proteins | 14 | 2024 | 1172 | 2.950 |
Why?
|
| Proteome | 20 | 2024 | 1856 | 2.760 |
Why?
|
| Amino Acids, Branched-Chain | 11 | 2024 | 263 | 2.420 |
Why?
|
| Cardiovascular Diseases | 42 | 2024 | 15740 | 2.200 |
Why?
|
| Aptamers, Nucleotide | 4 | 2020 | 171 | 1.810 |
Why?
|
| High-Throughput Screening Assays | 6 | 2020 | 943 | 1.340 |
Why?
|
| Diabetes Mellitus, Type 2 | 25 | 2024 | 12281 | 1.300 |
Why?
|
| Exercise | 21 | 2024 | 5783 | 1.260 |
Why?
|
| Guanidines | 2 | 2019 | 193 | 1.180 |
Why?
|
| Mass Spectrometry | 24 | 2021 | 2192 | 1.180 |
Why?
|
| Genome-Wide Association Study | 26 | 2024 | 12602 | 1.170 |
Why?
|
| Hypertrophy, Left Ventricular | 4 | 2021 | 853 | 1.130 |
Why?
|
| Carnitine | 7 | 2022 | 251 | 1.110 |
Why?
|
| Insulin Resistance | 20 | 2024 | 3960 | 1.070 |
Why?
|
| Metabolic Networks and Pathways | 7 | 2021 | 788 | 1.010 |
Why?
|
| Cardiovascular System | 3 | 2023 | 850 | 1.000 |
Why?
|
| Diabetes Mellitus | 8 | 2023 | 5884 | 0.960 |
Why?
|
| Leukotriene B4 | 5 | 2009 | 281 | 0.870 |
Why?
|
| Plasma | 5 | 2024 | 584 | 0.830 |
Why?
|
| Blood Glucose | 15 | 2024 | 6375 | 0.820 |
Why?
|
| Monocytes | 13 | 2017 | 2574 | 0.820 |
Why?
|
| Metabolic Diseases | 5 | 2019 | 685 | 0.810 |
Why?
|
| Aortic Valve Stenosis | 6 | 2023 | 2064 | 0.810 |
Why?
|
| Receptors, Leukotriene B4 | 4 | 2007 | 92 | 0.800 |
Why?
|
| Atherosclerosis | 13 | 2022 | 3524 | 0.800 |
Why?
|
| Immunoassay | 5 | 2020 | 748 | 0.790 |
Why?
|
| Chemokine CCL2 | 6 | 2012 | 607 | 0.760 |
Why?
|
| Coronary Disease | 5 | 2022 | 5993 | 0.760 |
Why?
|
| Chemokine CX3CL1 | 1 | 2021 | 64 | 0.750 |
Why?
|
| Humans | 249 | 2024 | 760261 | 0.730 |
Why?
|
| Chromatography, Liquid | 15 | 2019 | 987 | 0.720 |
Why?
|
| SELEX Aptamer Technique | 1 | 2019 | 18 | 0.700 |
Why?
|
| Tandem Mass Spectrometry | 10 | 2022 | 1190 | 0.690 |
Why?
|
| Keto Acids | 1 | 2019 | 34 | 0.680 |
Why?
|
| Cardiomyopathy, Hypertrophic | 3 | 2017 | 1300 | 0.660 |
Why?
|
| Cyanides | 5 | 2023 | 83 | 0.640 |
Why?
|
| Genomics | 6 | 2024 | 5790 | 0.630 |
Why?
|
| Quantitative Trait Loci | 8 | 2024 | 2101 | 0.620 |
Why?
|
| Triglycerides | 10 | 2023 | 2476 | 0.610 |
Why?
|
| Myocardial Infarction | 16 | 2023 | 11891 | 0.610 |
Why?
|
| Pentanoic Acids | 1 | 2017 | 19 | 0.610 |
Why?
|
| Betaine | 4 | 2021 | 89 | 0.600 |
Why?
|
| Phenylalanine | 4 | 2024 | 365 | 0.570 |
Why?
|
| Myocytes, Smooth Muscle | 3 | 2015 | 685 | 0.560 |
Why?
|
| Animals | 94 | 2024 | 167940 | 0.540 |
Why?
|
| Heart Failure | 13 | 2024 | 11835 | 0.540 |
Why?
|
| Tricarboxylic Acids | 1 | 2016 | 26 | 0.530 |
Why?
|
| S-Adenosylhomocysteine | 1 | 2016 | 41 | 0.530 |
Why?
|
| Aortic Aneurysm, Abdominal | 4 | 2011 | 1199 | 0.530 |
Why?
|
| Obesity | 19 | 2024 | 12915 | 0.530 |
Why?
|
| Male | 125 | 2024 | 359413 | 0.520 |
Why?
|
| Muscle, Smooth, Vascular | 4 | 2015 | 1484 | 0.520 |
Why?
|
| Middle Aged | 89 | 2024 | 220175 | 0.510 |
Why?
|
| Adipose Tissue, Brown | 4 | 2024 | 755 | 0.510 |
Why?
|
| Female | 129 | 2024 | 391011 | 0.500 |
Why?
|
| Choline | 3 | 2024 | 513 | 0.500 |
Why?
|
| 2-Aminoadipic Acid | 2 | 2022 | 33 | 0.500 |
Why?
|
| Risk Factors | 48 | 2024 | 74269 | 0.500 |
Why?
|
| Indoleamine-Pyrrole 2,3,-Dioxygenase | 1 | 2016 | 117 | 0.490 |
Why?
|
| Troponin I | 5 | 2015 | 634 | 0.490 |
Why?
|
| Endothelium, Vascular | 13 | 2020 | 4437 | 0.490 |
Why?
|
| Liver | 8 | 2019 | 7512 | 0.480 |
Why?
|
| Echocardiography | 6 | 2024 | 4980 | 0.480 |
Why?
|
| Mice | 60 | 2024 | 81216 | 0.470 |
Why?
|
| Uremia | 3 | 2015 | 201 | 0.460 |
Why?
|
| Aminoisobutyric Acids | 1 | 2014 | 39 | 0.460 |
Why?
|
| Phenotype | 23 | 2024 | 16543 | 0.460 |
Why?
|
| Energy Metabolism | 8 | 2024 | 2869 | 0.450 |
Why?
|
| Fatty Acids, Monounsaturated | 1 | 2015 | 190 | 0.450 |
Why?
|
| Chemotaxis, Leukocyte | 5 | 2008 | 663 | 0.450 |
Why?
|
| Coronary Artery Disease | 7 | 2024 | 6661 | 0.450 |
Why?
|
| Aptamers, Peptide | 4 | 2022 | 28 | 0.450 |
Why?
|
| Myocardium | 6 | 2019 | 4688 | 0.440 |
Why?
|
| Antibodies | 5 | 2022 | 2424 | 0.440 |
Why?
|
| Arginine | 2 | 2022 | 934 | 0.440 |
Why?
|
| Fatty Acids, Omega-6 | 1 | 2015 | 227 | 0.440 |
Why?
|
| Ventricular Dysfunction, Right | 2 | 2016 | 615 | 0.440 |
Why?
|
| Aged | 65 | 2024 | 168995 | 0.440 |
Why?
|
| Kidney Failure, Chronic | 4 | 2015 | 2469 | 0.430 |
Why?
|
| Purines | 2 | 2016 | 601 | 0.420 |
Why?
|
| Predictive Value of Tests | 15 | 2020 | 15273 | 0.420 |
Why?
|
| Endophenotypes | 1 | 2015 | 255 | 0.420 |
Why?
|
| Cardiac Pacing, Artificial | 2 | 2014 | 865 | 0.420 |
Why?
|
| Bile Acids and Salts | 2 | 2014 | 380 | 0.420 |
Why?
|
| Angina Pectoris | 2 | 2014 | 969 | 0.420 |
Why?
|
| Amino Acids | 7 | 2024 | 1715 | 0.420 |
Why?
|
| Genetic Variation | 7 | 2021 | 6540 | 0.420 |
Why?
|
| Longitudinal Studies | 14 | 2022 | 14482 | 0.410 |
Why?
|
| Hypertension, Pulmonary | 4 | 2018 | 1570 | 0.410 |
Why?
|
| Ventricular Remodeling | 3 | 2022 | 1259 | 0.410 |
Why?
|
| Myocytes, Cardiac | 8 | 2022 | 1656 | 0.410 |
Why?
|
| Cholesterol, HDL | 10 | 2024 | 1817 | 0.410 |
Why?
|
| Vascular Cell Adhesion Molecule-1 | 7 | 2006 | 694 | 0.390 |
Why?
|
| Reproducibility of Results | 17 | 2023 | 20048 | 0.390 |
Why?
|
| Case-Control Studies | 20 | 2022 | 22041 | 0.390 |
Why?
|
| Adipose Tissue, White | 2 | 2014 | 365 | 0.390 |
Why?
|
| Antidotes | 4 | 2023 | 138 | 0.380 |
Why?
|
| Nitric Oxide | 3 | 2021 | 2141 | 0.380 |
Why?
|
| Adult | 59 | 2024 | 219847 | 0.380 |
Why?
|
| Kynurenine | 3 | 2021 | 140 | 0.370 |
Why?
|
| Glucose Tolerance Test | 6 | 2015 | 1174 | 0.360 |
Why?
|
| Leukocytes | 4 | 2021 | 2030 | 0.360 |
Why?
|
| Mice, Inbred C57BL | 27 | 2024 | 22025 | 0.360 |
Why?
|
| Glucose | 10 | 2023 | 4361 | 0.360 |
Why?
|
| Chemokine CXCL10 | 2 | 2009 | 316 | 0.350 |
Why?
|
| Prediabetic State | 4 | 2021 | 550 | 0.350 |
Why?
|
| Incidence | 17 | 2024 | 21378 | 0.350 |
Why?
|
| Heart Valve Prosthesis Implantation | 2 | 2021 | 1583 | 0.340 |
Why?
|
| Stroke | 7 | 2023 | 9945 | 0.340 |
Why?
|
| Fibroblast Growth Factors | 4 | 2022 | 867 | 0.340 |
Why?
|
| Myocardial Contraction | 2 | 2014 | 1516 | 0.340 |
Why?
|
| AMP-Activated Protein Kinases | 6 | 2019 | 600 | 0.340 |
Why?
|
| Benzopyrans | 1 | 2009 | 63 | 0.340 |
Why?
|
| Polymorphism, Single Nucleotide | 13 | 2023 | 15766 | 0.340 |
Why?
|
| Myocardial Ischemia | 5 | 2023 | 2161 | 0.340 |
Why?
|
| Carboxylic Acids | 1 | 2009 | 90 | 0.330 |
Why?
|
| Kynurenic Acid | 1 | 2009 | 44 | 0.330 |
Why?
|
| Electronic Health Records | 2 | 2024 | 4763 | 0.330 |
Why?
|
| Chemokines, CXC | 3 | 2006 | 421 | 0.330 |
Why?
|
| Kinetics | 5 | 2023 | 6378 | 0.330 |
Why?
|
| Sarcosine | 2 | 2021 | 16 | 0.320 |
Why?
|
| Metabolism | 2 | 2011 | 193 | 0.320 |
Why?
|
| Cell Adhesion | 11 | 2009 | 3096 | 0.320 |
Why?
|
| Gene Deletion | 4 | 2019 | 2668 | 0.320 |
Why?
|
| Muscle, Skeletal | 6 | 2023 | 4923 | 0.320 |
Why?
|
| Chemistry, Clinical | 1 | 2009 | 64 | 0.320 |
Why?
|
| Myocardial Reperfusion Injury | 2 | 2023 | 479 | 0.310 |
Why?
|
| Diet | 10 | 2022 | 8008 | 0.310 |
Why?
|
| Amino Acids, Aromatic | 3 | 2013 | 36 | 0.310 |
Why?
|
| Adipose Tissue | 4 | 2022 | 3293 | 0.310 |
Why?
|
| Cohort Studies | 26 | 2024 | 41317 | 0.310 |
Why?
|
| Metformin | 4 | 2024 | 912 | 0.300 |
Why?
|
| Risk Assessment | 17 | 2024 | 24086 | 0.300 |
Why?
|
| Interleukins | 2 | 2009 | 782 | 0.300 |
Why?
|
| Zebrafish | 7 | 2022 | 2996 | 0.300 |
Why?
|
| Docosahexaenoic Acids | 1 | 2015 | 912 | 0.300 |
Why?
|
| Diagnostic Techniques, Cardiovascular | 1 | 2009 | 152 | 0.300 |
Why?
|
| Apolipoproteins E | 8 | 2017 | 1437 | 0.300 |
Why?
|
| Blood | 1 | 2010 | 586 | 0.300 |
Why?
|
| Acute Kidney Injury | 2 | 2020 | 1935 | 0.290 |
Why?
|
| Computational Biology | 8 | 2022 | 3504 | 0.290 |
Why?
|
| Induced Pluripotent Stem Cells | 6 | 2022 | 1843 | 0.290 |
Why?
|
| Anthracyclines | 3 | 2022 | 283 | 0.280 |
Why?
|
| Data Mining | 2 | 2020 | 553 | 0.280 |
Why?
|
| Weight Loss | 3 | 2021 | 2683 | 0.270 |
Why?
|
| Heart Injuries | 1 | 2008 | 208 | 0.270 |
Why?
|
| Aortic Aneurysm | 1 | 2011 | 646 | 0.270 |
Why?
|
| Endothelial Cells | 4 | 2021 | 3537 | 0.270 |
Why?
|
| Stroke Volume | 7 | 2024 | 5513 | 0.270 |
Why?
|
| Genome, Human | 3 | 2021 | 4416 | 0.270 |
Why?
|
| Insulin | 11 | 2024 | 6592 | 0.270 |
Why?
|
| Receptors, Chemokine | 3 | 2006 | 654 | 0.260 |
Why?
|
| Cell Line | 15 | 2020 | 15626 | 0.260 |
Why?
|
| Glyoxylates | 2 | 2023 | 11 | 0.260 |
Why?
|
| Biomedical Technology | 1 | 2008 | 211 | 0.260 |
Why?
|
| Intra-Abdominal Fat | 2 | 2022 | 607 | 0.260 |
Why?
|
| Signal Transduction | 18 | 2024 | 23363 | 0.260 |
Why?
|
| Exercise Test | 4 | 2024 | 2125 | 0.260 |
Why?
|
| Aortic Rupture | 1 | 2009 | 313 | 0.260 |
Why?
|
| Hypoglycemic Agents | 5 | 2024 | 3149 | 0.260 |
Why?
|
| Hip Fractures | 2 | 2024 | 989 | 0.260 |
Why?
|
| Cardiotonic Agents | 1 | 2009 | 546 | 0.260 |
Why?
|
| Mitochondria | 3 | 2024 | 3598 | 0.260 |
Why?
|
| Prospective Studies | 30 | 2024 | 54263 | 0.250 |
Why?
|
| Leukocytes, Mononuclear | 3 | 2017 | 1828 | 0.250 |
Why?
|
| Adipocytes, Brown | 3 | 2024 | 149 | 0.250 |
Why?
|
| Lipid Metabolism | 6 | 2021 | 1902 | 0.250 |
Why?
|
| Lipids | 5 | 2022 | 3336 | 0.250 |
Why?
|
| Eating | 2 | 2024 | 1538 | 0.250 |
Why?
|
| Mice, Knockout | 20 | 2023 | 14396 | 0.250 |
Why?
|
| Diabetes, Gestational | 1 | 2015 | 1241 | 0.250 |
Why?
|
| Natriuretic Peptide, Brain | 7 | 2024 | 1705 | 0.240 |
Why?
|
| Adipocytes, White | 3 | 2017 | 91 | 0.240 |
Why?
|
| Models, Genetic | 4 | 2024 | 3442 | 0.240 |
Why?
|
| Asthma | 5 | 2024 | 6167 | 0.230 |
Why?
|
| Proteins | 3 | 2022 | 6030 | 0.230 |
Why?
|
| Lactic Acid | 4 | 2022 | 1132 | 0.230 |
Why?
|
| Doxorubicin | 4 | 2022 | 2207 | 0.230 |
Why?
|
| Receptors, Purinergic P2 | 1 | 2005 | 152 | 0.230 |
Why?
|
| Growth Differentiation Factor 10 | 1 | 2023 | 4 | 0.230 |
Why?
|
| Coronary Sinus | 3 | 2019 | 84 | 0.230 |
Why?
|
| T-Lymphocytes | 5 | 2007 | 10183 | 0.230 |
Why?
|
| Receptors, Cell Surface | 4 | 2012 | 2825 | 0.230 |
Why?
|
| Macrophages | 5 | 2012 | 5745 | 0.230 |
Why?
|
| Dyslipidemias | 4 | 2016 | 895 | 0.220 |
Why?
|
| Peptide Fragments | 7 | 2024 | 5120 | 0.220 |
Why?
|
| Barth Syndrome | 1 | 2023 | 25 | 0.220 |
Why?
|
| Homeostasis | 8 | 2023 | 3305 | 0.220 |
Why?
|
| Oleic Acids | 1 | 2023 | 74 | 0.210 |
Why?
|
| MicroRNAs | 5 | 2024 | 3784 | 0.210 |
Why?
|
| Cells, Cultured | 16 | 2021 | 18968 | 0.210 |
Why?
|
| Thermogenesis | 2 | 2024 | 468 | 0.210 |
Why?
|
| Logistic Models | 10 | 2021 | 13311 | 0.210 |
Why?
|
| Sickle Cell Trait | 1 | 2023 | 85 | 0.210 |
Why?
|
| Physical Endurance | 2 | 2023 | 363 | 0.210 |
Why?
|
| Alzheimer Disease | 5 | 2023 | 8551 | 0.210 |
Why?
|
| National Heart, Lung, and Blood Institute (U.S.) | 2 | 2021 | 323 | 0.210 |
Why?
|
| Renal Insufficiency, Chronic | 4 | 2018 | 2296 | 0.210 |
Why?
|
| Ketoglutaric Acids | 2 | 2022 | 75 | 0.210 |
Why?
|
| Massachusetts | 7 | 2021 | 8805 | 0.210 |
Why?
|
| Nucleosides | 2 | 2022 | 131 | 0.210 |
Why?
|
| Nitrogen | 1 | 2024 | 350 | 0.210 |
Why?
|
| Pulmonary Disease, Chronic Obstructive | 3 | 2023 | 3223 | 0.210 |
Why?
|
| Body Mass Index | 10 | 2022 | 12901 | 0.210 |
Why?
|
| Longevity | 2 | 2024 | 1050 | 0.210 |
Why?
|
| Gastric Bypass | 1 | 2011 | 826 | 0.210 |
Why?
|
| Hep G2 Cells | 3 | 2018 | 389 | 0.200 |
Why?
|
| Body Composition | 3 | 2024 | 2418 | 0.200 |
Why?
|
| Oxygen Consumption | 4 | 2023 | 1840 | 0.200 |
Why?
|
| Proportional Hazards Models | 7 | 2022 | 12532 | 0.200 |
Why?
|
| Receptors, Urokinase Plasminogen Activator | 1 | 2021 | 75 | 0.200 |
Why?
|
| Risk | 6 | 2021 | 9629 | 0.200 |
Why?
|
| Resistance Training | 1 | 2024 | 185 | 0.200 |
Why?
|
| Brugada Syndrome | 1 | 2022 | 95 | 0.190 |
Why?
|
| Adipocytes | 2 | 2019 | 1179 | 0.190 |
Why?
|
| Poisoning | 1 | 2023 | 252 | 0.190 |
Why?
|
| Homoarginine | 1 | 2021 | 9 | 0.190 |
Why?
|
| Orotic Acid | 1 | 2021 | 24 | 0.190 |
Why?
|
| Brain Ischemia | 2 | 2013 | 3127 | 0.190 |
Why?
|
| Receptor, TIE-2 | 1 | 2021 | 177 | 0.190 |
Why?
|
| Spermine | 1 | 2021 | 69 | 0.190 |
Why?
|
| Dementia | 3 | 2023 | 2638 | 0.180 |
Why?
|
| Life Style | 3 | 2021 | 3888 | 0.180 |
Why?
|
| Heart | 3 | 2023 | 4392 | 0.180 |
Why?
|
| Atrial Fibrillation | 4 | 2023 | 5201 | 0.180 |
Why?
|
| Protective Agents | 1 | 2021 | 150 | 0.180 |
Why?
|
| Uridine | 1 | 2021 | 142 | 0.180 |
Why?
|
| Cholesterol | 6 | 2017 | 2925 | 0.180 |
Why?
|
| Polyamines | 1 | 2021 | 133 | 0.180 |
Why?
|
| Interferon-gamma | 1 | 2009 | 3160 | 0.180 |
Why?
|
| Cell Differentiation | 6 | 2017 | 11480 | 0.180 |
Why?
|
| Glycerophosphates | 1 | 2020 | 47 | 0.180 |
Why?
|
| Methylamines | 1 | 2021 | 138 | 0.180 |
Why?
|
| Interleukin-8 | 2 | 2022 | 698 | 0.170 |
Why?
|
| Fatty Liver | 3 | 2021 | 777 | 0.170 |
Why?
|
| E-Selectin | 4 | 2002 | 576 | 0.170 |
Why?
|
| Receptors, G-Protein-Coupled | 3 | 2019 | 1244 | 0.170 |
Why?
|
| Tunica Intima | 1 | 2002 | 459 | 0.170 |
Why?
|
| Respiratory Syncytial Virus, Human | 1 | 2022 | 149 | 0.170 |
Why?
|
| Cystatin C | 1 | 2021 | 270 | 0.170 |
Why?
|
| Chemokines | 2 | 2021 | 962 | 0.170 |
Why?
|
| Cardiovascular Physiological Phenomena | 1 | 2021 | 239 | 0.170 |
Why?
|
| Glycolysis | 3 | 2021 | 828 | 0.170 |
Why?
|
| Antibiotics, Antineoplastic | 2 | 2022 | 675 | 0.170 |
Why?
|
| Cross-Sectional Studies | 14 | 2024 | 25928 | 0.170 |
Why?
|
| Muscle Fibers, Skeletal | 1 | 2022 | 543 | 0.160 |
Why?
|
| Malates | 1 | 2019 | 34 | 0.160 |
Why?
|
| Proline | 1 | 2021 | 457 | 0.160 |
Why?
|
| Mendelian Randomization Analysis | 3 | 2022 | 989 | 0.160 |
Why?
|
| Organ Specificity | 2 | 2014 | 1955 | 0.160 |
Why?
|
| Potassium Cyanide | 1 | 2018 | 17 | 0.160 |
Why?
|
| Transforming Growth Factor beta1 | 2 | 2016 | 613 | 0.160 |
Why?
|
| Sodium-Glucose Transporter 2 | 1 | 2019 | 98 | 0.160 |
Why?
|
| Thrombospondins | 1 | 2019 | 193 | 0.160 |
Why?
|
| Odds Ratio | 8 | 2020 | 9712 | 0.160 |
Why?
|
| Succinic Acid | 1 | 2019 | 84 | 0.160 |
Why?
|
| Activin Receptors, Type II | 1 | 2019 | 123 | 0.150 |
Why?
|
| Cytosine | 1 | 2019 | 212 | 0.150 |
Why?
|
| Viruses | 1 | 2022 | 376 | 0.150 |
Why?
|
| Kidney Function Tests | 3 | 2020 | 680 | 0.150 |
Why?
|
| Rats | 8 | 2022 | 23695 | 0.150 |
Why?
|
| Anti-Obesity Agents | 1 | 2021 | 229 | 0.150 |
Why?
|
| Citric Acid Cycle | 1 | 2019 | 230 | 0.150 |
Why?
|
| Aged, 80 and over | 16 | 2024 | 58947 | 0.150 |
Why?
|
| Prognosis | 11 | 2021 | 29636 | 0.150 |
Why?
|
| Death, Sudden, Cardiac | 2 | 2024 | 1572 | 0.150 |
Why?
|
| Pyruvate Dehydrogenase Complex | 1 | 2018 | 63 | 0.150 |
Why?
|
| Vascular Resistance | 3 | 2018 | 932 | 0.150 |
Why?
|
| RNA Processing, Post-Transcriptional | 1 | 2021 | 414 | 0.150 |
Why?
|
| Gene Expression Profiling | 7 | 2019 | 9388 | 0.150 |
Why?
|
| Overweight | 2 | 2021 | 2421 | 0.150 |
Why?
|
| Phosphatidylinositol 3-Kinases | 3 | 2022 | 2866 | 0.150 |
Why?
|
| Time Factors | 17 | 2024 | 40133 | 0.150 |
Why?
|
| Specimen Handling | 1 | 2022 | 708 | 0.140 |
Why?
|
| Amino Acid Transport Systems, Basic | 1 | 2017 | 33 | 0.140 |
Why?
|
| Gait | 2 | 2022 | 812 | 0.140 |
Why?
|
| Renal Insufficiency | 1 | 2023 | 820 | 0.140 |
Why?
|
| Blood Pressure | 5 | 2024 | 8523 | 0.140 |
Why?
|
| Protein Array Analysis | 2 | 2009 | 401 | 0.140 |
Why?
|
| Respiratory Syncytial Virus Infections | 1 | 2022 | 364 | 0.140 |
Why?
|
| Heredity | 1 | 2017 | 148 | 0.140 |
Why?
|
| Aging | 5 | 2024 | 8641 | 0.140 |
Why?
|
| Intracranial Embolism | 1 | 2019 | 192 | 0.140 |
Why?
|
| Proteoglycans | 1 | 2020 | 802 | 0.140 |
Why?
|
| Interferon Regulatory Factor-1 | 1 | 2017 | 68 | 0.140 |
Why?
|
| Receptors, Thrombin | 2 | 1995 | 132 | 0.140 |
Why?
|
| Diffusion of Innovation | 2 | 2019 | 730 | 0.140 |
Why?
|
| Body Constitution | 1 | 2017 | 273 | 0.140 |
Why?
|
| Kidney | 5 | 2020 | 7072 | 0.140 |
Why?
|
| Lung | 4 | 2024 | 9989 | 0.140 |
Why?
|
| American Heart Association | 3 | 2017 | 1081 | 0.140 |
Why?
|
| Genetic Predisposition to Disease | 8 | 2021 | 17766 | 0.140 |
Why?
|
| Tea | 1 | 2018 | 284 | 0.140 |
Why?
|
| Diet, Reducing | 2 | 2021 | 487 | 0.140 |
Why?
|
| Follow-Up Studies | 14 | 2022 | 39254 | 0.140 |
Why?
|
| Platelet Activation | 1 | 2020 | 661 | 0.140 |
Why?
|
| Automation | 1 | 2019 | 581 | 0.140 |
Why?
|
| Peptidyl-Dipeptidase A | 1 | 2018 | 361 | 0.140 |
Why?
|
| United States | 17 | 2023 | 72363 | 0.130 |
Why?
|
| Xanthines | 1 | 2016 | 122 | 0.130 |
Why?
|
| Antibody Affinity | 1 | 2017 | 245 | 0.130 |
Why?
|
| Ribonucleosides | 1 | 2016 | 79 | 0.130 |
Why?
|
| Adaptation, Physiological | 1 | 2023 | 1297 | 0.130 |
Why?
|
| Dyspnea | 1 | 2024 | 1352 | 0.130 |
Why?
|
| Bronchiolitis | 1 | 2022 | 479 | 0.130 |
Why?
|
| Arteriosclerosis | 1 | 2000 | 1064 | 0.130 |
Why?
|
| Smoking | 3 | 2020 | 9070 | 0.130 |
Why?
|
| Alanine | 1 | 2018 | 607 | 0.130 |
Why?
|
| Sensitivity and Specificity | 6 | 2019 | 14656 | 0.130 |
Why?
|
| Molecular Structure | 2 | 2011 | 1895 | 0.130 |
Why?
|
| Dimethylglycine Dehydrogenase | 1 | 2015 | 2 | 0.130 |
Why?
|
| Cardiotoxins | 1 | 2015 | 37 | 0.130 |
Why?
|
| Amines | 1 | 2017 | 281 | 0.130 |
Why?
|
| Isocitrates | 1 | 2015 | 23 | 0.130 |
Why?
|
| Nicotinamide Phosphoribosyltransferase | 1 | 2015 | 84 | 0.130 |
Why?
|
| Taurocholic Acid | 1 | 2015 | 43 | 0.130 |
Why?
|
| Rodent Diseases | 1 | 2015 | 53 | 0.130 |
Why?
|
| Membrane Glycoproteins | 2 | 2004 | 3731 | 0.130 |
Why?
|
| Gene Targeting | 2 | 2011 | 839 | 0.130 |
Why?
|
| Disease Models, Animal | 11 | 2023 | 18134 | 0.130 |
Why?
|
| Lipolysis | 2 | 2014 | 211 | 0.120 |
Why?
|
| Flow Cytometry | 8 | 2011 | 5873 | 0.120 |
Why?
|
| Body Weight | 2 | 2024 | 4613 | 0.120 |
Why?
|
| Heart Diseases | 3 | 2019 | 2809 | 0.120 |
Why?
|
| Ablation Techniques | 1 | 2017 | 249 | 0.120 |
Why?
|
| Mobility Limitation | 1 | 2019 | 402 | 0.120 |
Why?
|
| Databases, Factual | 2 | 2023 | 8018 | 0.120 |
Why?
|
| Fatty Acids | 3 | 2023 | 1805 | 0.120 |
Why?
|
| Young Adult | 9 | 2024 | 58673 | 0.120 |
Why?
|
| Proto-Oncogene Proteins c-akt | 4 | 2019 | 2449 | 0.120 |
Why?
|
| Membrane Transport Proteins | 1 | 2020 | 1036 | 0.120 |
Why?
|
| Renal Dialysis | 3 | 2015 | 1802 | 0.120 |
Why?
|
| Mice, 129 Strain | 2 | 2014 | 373 | 0.120 |
Why?
|
| Carotid Artery Diseases | 2 | 2018 | 881 | 0.120 |
Why?
|
| DNA, Single-Stranded | 1 | 2016 | 360 | 0.120 |
Why?
|
| Phosphoric Diester Hydrolases | 1 | 2015 | 199 | 0.120 |
Why?
|
| Peroxidase | 2 | 2016 | 604 | 0.120 |
Why?
|
| Gas Chromatography-Mass Spectrometry | 1 | 2015 | 352 | 0.120 |
Why?
|
| Dermatitis, Atopic | 1 | 2021 | 710 | 0.120 |
Why?
|
| Actinin | 2 | 2006 | 163 | 0.120 |
Why?
|
| Sterol Regulatory Element Binding Proteins | 2 | 2011 | 25 | 0.120 |
Why?
|
| Tryptophan Hydroxylase | 1 | 2014 | 94 | 0.110 |
Why?
|
| Caffeine | 1 | 2018 | 701 | 0.110 |
Why?
|
| Gene Frequency | 2 | 2022 | 3605 | 0.110 |
Why?
|
| Information Dissemination | 1 | 2022 | 1132 | 0.110 |
Why?
|
| Oxidation-Reduction | 3 | 2017 | 2222 | 0.110 |
Why?
|
| Hypertension | 4 | 2024 | 8595 | 0.110 |
Why?
|
| Adaptor Proteins, Signal Transducing | 2 | 2021 | 2895 | 0.110 |
Why?
|
| Thrombin | 3 | 2002 | 593 | 0.110 |
Why?
|
| Cholesterol Esters | 1 | 2013 | 73 | 0.110 |
Why?
|
| Cardiac Imaging Techniques | 1 | 2016 | 269 | 0.110 |
Why?
|
| Cholesterol, LDL | 3 | 2022 | 2422 | 0.110 |
Why?
|
| Finland | 1 | 2015 | 602 | 0.110 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 4 | 2019 | 11708 | 0.110 |
Why?
|
| Hyperglycemia | 1 | 2022 | 1380 | 0.110 |
Why?
|
| Parabiosis | 1 | 2013 | 64 | 0.110 |
Why?
|
| Diet, Mediterranean | 1 | 2020 | 732 | 0.110 |
Why?
|
| Heterocyclic Compounds | 1 | 2014 | 247 | 0.110 |
Why?
|
| Parathion | 1 | 2012 | 14 | 0.110 |
Why?
|
| Pulmonary Circulation | 1 | 2016 | 743 | 0.110 |
Why?
|
| Receptors, LDL | 1 | 2015 | 491 | 0.110 |
Why?
|
| Receptors, CCR2 | 2 | 2005 | 215 | 0.100 |
Why?
|
| National Institutes of Health (U.S.) | 1 | 2016 | 787 | 0.100 |
Why?
|
| Heart Atria | 1 | 2019 | 1344 | 0.100 |
Why?
|
| Transaminases | 1 | 2013 | 196 | 0.100 |
Why?
|
| Riboflavin | 1 | 2013 | 105 | 0.100 |
Why?
|
| PPAR alpha | 1 | 2014 | 174 | 0.100 |
Why?
|
| Thrombosis | 3 | 2020 | 3052 | 0.100 |
Why?
|
| Forecasting | 2 | 2019 | 2931 | 0.100 |
Why?
|
| Genetic Association Studies | 1 | 2022 | 2716 | 0.100 |
Why?
|
| Collagen | 1 | 2021 | 2635 | 0.100 |
Why?
|
| Tissue Culture Techniques | 1 | 2013 | 290 | 0.100 |
Why?
|
| Growth Differentiation Factors | 1 | 2013 | 99 | 0.100 |
Why?
|
| Chemokines, CC | 2 | 2005 | 283 | 0.100 |
Why?
|
| Carbohydrates | 1 | 2014 | 388 | 0.100 |
Why?
|
| Health | 1 | 2015 | 395 | 0.100 |
Why?
|
| Serum Albumin | 1 | 2015 | 674 | 0.100 |
Why?
|
| Cytokines | 2 | 2018 | 7345 | 0.100 |
Why?
|
| Up-Regulation | 3 | 2017 | 4127 | 0.100 |
Why?
|
| Nuclear Magnetic Resonance, Biomolecular | 1 | 2015 | 511 | 0.100 |
Why?
|
| Chromatography, Gas | 1 | 2011 | 151 | 0.100 |
Why?
|
| Intercellular Adhesion Molecule-1 | 3 | 2009 | 1128 | 0.100 |
Why?
|
| Respiratory Insufficiency | 1 | 2020 | 1228 | 0.100 |
Why?
|
| Mice, Transgenic | 6 | 2016 | 9531 | 0.100 |
Why?
|
| Immunohistochemistry | 5 | 2012 | 11064 | 0.100 |
Why?
|
| Zebrafish Proteins | 1 | 2018 | 1006 | 0.100 |
Why?
|
| Osteopontin | 1 | 2013 | 302 | 0.100 |
Why?
|
| Multifactorial Inheritance | 1 | 2020 | 1351 | 0.100 |
Why?
|
| Nutritional Status | 2 | 2020 | 1606 | 0.100 |
Why?
|
| Spectrometry, Mass, Electrospray Ionization | 2 | 2019 | 267 | 0.100 |
Why?
|
| NAD | 1 | 2015 | 610 | 0.100 |
Why?
|
| Ischemia | 1 | 2020 | 1893 | 0.100 |
Why?
|
| Leukocytosis | 1 | 2013 | 251 | 0.100 |
Why?
|
| Antibodies, Neutralizing | 1 | 2021 | 1933 | 0.100 |
Why?
|
| Thyroid Hormones | 1 | 2014 | 403 | 0.100 |
Why?
|
| I-kappa B Kinase | 2 | 2011 | 251 | 0.090 |
Why?
|
| Nucleotides | 2 | 2012 | 450 | 0.090 |
Why?
|
| Preventive Health Services | 1 | 2016 | 571 | 0.090 |
Why?
|
| Peptide Mapping | 1 | 2011 | 262 | 0.090 |
Why?
|
| Adiposity | 2 | 2019 | 1851 | 0.090 |
Why?
|
| Gastrointestinal Motility | 1 | 2013 | 234 | 0.090 |
Why?
|
| Culture Media, Conditioned | 2 | 2022 | 522 | 0.090 |
Why?
|
| ROC Curve | 3 | 2021 | 3568 | 0.090 |
Why?
|
| Biological Assay | 2 | 2011 | 630 | 0.090 |
Why?
|
| Liver Cirrhosis | 1 | 2021 | 1925 | 0.090 |
Why?
|
| Postprandial Period | 1 | 2013 | 315 | 0.090 |
Why?
|
| Statistics as Topic | 2 | 2016 | 2363 | 0.090 |
Why?
|
| Comorbidity | 3 | 2015 | 10552 | 0.090 |
Why?
|
| Cisplatin | 1 | 2017 | 1642 | 0.090 |
Why?
|
| Child Nutrition Disorders | 1 | 2012 | 150 | 0.090 |
Why?
|
| Diabetes Complications | 1 | 2018 | 1342 | 0.090 |
Why?
|
| Databases, Genetic | 1 | 2017 | 1739 | 0.090 |
Why?
|
| Genetic Markers | 1 | 2017 | 2608 | 0.090 |
Why?
|
| Pregnancy Trimester, First | 1 | 2015 | 909 | 0.090 |
Why?
|
| Troponin T | 2 | 2016 | 774 | 0.090 |
Why?
|
| Biogenic Amines | 1 | 2010 | 53 | 0.090 |
Why?
|
| ATP-Binding Cassette Transporters | 2 | 2011 | 563 | 0.090 |
Why?
|
| Cardiomegaly | 1 | 2013 | 593 | 0.090 |
Why?
|
| Kininogens | 1 | 2009 | 15 | 0.090 |
Why?
|
| Nuclear Receptor Subfamily 4, Group A, Member 1 | 1 | 2010 | 67 | 0.090 |
Why?
|
| Aorta | 2 | 2009 | 2042 | 0.090 |
Why?
|
| Physical Conditioning, Animal | 1 | 2014 | 366 | 0.090 |
Why?
|
| Angiotensin II | 2 | 2011 | 850 | 0.090 |
Why?
|
| Adipokines | 2 | 2022 | 311 | 0.090 |
Why?
|
| Program Development | 1 | 2016 | 1297 | 0.090 |
Why?
|
| Linear Models | 2 | 2020 | 5876 | 0.090 |
Why?
|
| Biological Transport | 3 | 2024 | 2087 | 0.090 |
Why?
|
| Gastrointestinal Tract | 1 | 2016 | 830 | 0.090 |
Why?
|
| Umbilical Veins | 3 | 2000 | 426 | 0.090 |
Why?
|
| Rabbits | 4 | 2017 | 4773 | 0.090 |
Why?
|
| Dicarboxylic Acids | 1 | 2010 | 77 | 0.090 |
Why?
|
| Area Under Curve | 3 | 2021 | 1635 | 0.090 |
Why?
|
| Sphingomyelins | 1 | 2010 | 103 | 0.090 |
Why?
|
| Antibodies, Viral | 1 | 2021 | 3145 | 0.090 |
Why?
|
| Indicator Dilution Techniques | 1 | 2009 | 43 | 0.090 |
Why?
|
| DNA, Complementary | 2 | 2004 | 1993 | 0.090 |
Why?
|
| Serum Amyloid P-Component | 1 | 2009 | 46 | 0.090 |
Why?
|
| Diglycerides | 2 | 2021 | 176 | 0.090 |
Why?
|
| Podocytes | 2 | 2020 | 402 | 0.080 |
Why?
|
| Microfilament Proteins | 2 | 2006 | 1134 | 0.080 |
Why?
|
| Sleep Apnea, Obstructive | 1 | 2022 | 1859 | 0.080 |
Why?
|
| Enzyme Inhibitors | 2 | 2015 | 3726 | 0.080 |
Why?
|
| Sex Distribution | 1 | 2015 | 2295 | 0.080 |
Why?
|
| Isocitrate Dehydrogenase | 1 | 2015 | 927 | 0.080 |
Why?
|
| Pulmonary Artery | 1 | 2018 | 1919 | 0.080 |
Why?
|
| Transcription, Genetic | 3 | 2015 | 7593 | 0.080 |
Why?
|
| Blood Chemical Analysis | 1 | 2011 | 437 | 0.080 |
Why?
|
| Oxyquinoline | 2 | 2008 | 16 | 0.080 |
Why?
|
| Kidney Diseases | 3 | 2013 | 2093 | 0.080 |
Why?
|
| Glucose Intolerance | 2 | 2016 | 579 | 0.080 |
Why?
|
| Rats, Wistar | 1 | 2013 | 1849 | 0.080 |
Why?
|
| Nerve Growth Factors | 1 | 2012 | 562 | 0.080 |
Why?
|
| Environmental Exposure | 1 | 2024 | 4404 | 0.080 |
Why?
|
| Gene Expression | 4 | 2021 | 7592 | 0.080 |
Why?
|
| Chromatography, High Pressure Liquid | 2 | 2019 | 1549 | 0.080 |
Why?
|
| Electrocardiography | 3 | 2019 | 6413 | 0.080 |
Why?
|
| Age Distribution | 1 | 2015 | 2893 | 0.080 |
Why?
|
| Genotype | 7 | 2020 | 12959 | 0.080 |
Why?
|
| Isotopes | 1 | 2008 | 125 | 0.080 |
Why?
|
| Kaplan-Meier Estimate | 2 | 2017 | 6545 | 0.080 |
Why?
|
| Gene Transfer Techniques | 3 | 1999 | 1204 | 0.080 |
Why?
|
| X-Ray Microtomography | 1 | 2011 | 444 | 0.080 |
Why?
|
| Pyrimidines | 1 | 2021 | 3011 | 0.080 |
Why?
|
| Aortic Valve | 3 | 2023 | 1996 | 0.080 |
Why?
|
| Breast Neoplasms | 5 | 2019 | 21065 | 0.080 |
Why?
|
| Drug Discovery | 1 | 2016 | 1056 | 0.080 |
Why?
|
| Transgenes | 1 | 2012 | 1006 | 0.080 |
Why?
|
| Cardiovascular Agents | 1 | 2015 | 864 | 0.080 |
Why?
|
| Treatment Outcome | 11 | 2023 | 64947 | 0.080 |
Why?
|
| Constipation | 1 | 2013 | 561 | 0.080 |
Why?
|
| Lipoproteins | 3 | 2018 | 882 | 0.080 |
Why?
|
| Dietary Proteins | 2 | 2012 | 949 | 0.080 |
Why?
|
| Fasting | 4 | 2019 | 1603 | 0.080 |
Why?
|
| Rheology | 1 | 2009 | 348 | 0.080 |
Why?
|
| Chromatography, Affinity | 1 | 2009 | 534 | 0.080 |
Why?
|
| Cell Lineage | 2 | 2015 | 2525 | 0.080 |
Why?
|
| Inosine | 2 | 2022 | 130 | 0.080 |
Why?
|
| Bone Morphogenetic Proteins | 1 | 2013 | 840 | 0.070 |
Why?
|
| Isotope Labeling | 1 | 2009 | 392 | 0.070 |
Why?
|
| Alcohol Drinking | 1 | 2020 | 4012 | 0.070 |
Why?
|
| Regional Blood Flow | 2 | 2020 | 1490 | 0.070 |
Why?
|
| Cell Migration Inhibition | 1 | 2007 | 97 | 0.070 |
Why?
|
| Ventricular Function, Left | 4 | 2024 | 3870 | 0.070 |
Why?
|
| Diabetic Angiopathies | 1 | 2012 | 822 | 0.070 |
Why?
|
| Adenoviridae | 3 | 2002 | 1084 | 0.070 |
Why?
|
| Multivariate Analysis | 3 | 2016 | 12156 | 0.070 |
Why?
|
| Nuclear Proteins | 1 | 2022 | 5793 | 0.070 |
Why?
|
| Leucine | 2 | 2023 | 548 | 0.070 |
Why?
|
| Osteonectin | 1 | 2006 | 33 | 0.070 |
Why?
|
| Sex Factors | 1 | 2021 | 10530 | 0.070 |
Why?
|
| Gene Silencing | 1 | 2013 | 1511 | 0.070 |
Why?
|
| Motor Activity | 2 | 2015 | 2687 | 0.070 |
Why?
|
| Peptide Library | 1 | 2008 | 347 | 0.070 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 3 | 2017 | 3774 | 0.070 |
Why?
|
| Pulmonary Wedge Pressure | 2 | 2024 | 273 | 0.070 |
Why?
|
| Antineoplastic Agents | 3 | 2015 | 13629 | 0.070 |
Why?
|
| Feasibility Studies | 1 | 2017 | 5201 | 0.070 |
Why?
|
| Neovascularization, Physiologic | 2 | 2015 | 1335 | 0.070 |
Why?
|
| Adolescent | 8 | 2024 | 87747 | 0.070 |
Why?
|
| Epidemiologic Methods | 1 | 2011 | 1344 | 0.070 |
Why?
|
| Excitatory Amino Acid Antagonists | 1 | 2009 | 448 | 0.070 |
Why?
|
| Chemotaxis | 1 | 2009 | 598 | 0.070 |
Why?
|
| Diet, Carbohydrate-Restricted | 1 | 2009 | 261 | 0.070 |
Why?
|
| Phosphodiesterase Inhibitors | 1 | 2007 | 214 | 0.070 |
Why?
|
| Metal Nanoparticles | 1 | 2011 | 401 | 0.070 |
Why?
|
| Child | 9 | 2024 | 79758 | 0.070 |
Why?
|
| Troponin | 1 | 2010 | 516 | 0.070 |
Why?
|
| Pyruvate Kinase | 1 | 2008 | 190 | 0.070 |
Why?
|
| Chemokine CCL19 | 1 | 2005 | 35 | 0.070 |
Why?
|
| B-Lymphocytes | 1 | 2019 | 4739 | 0.070 |
Why?
|
| Phenols | 1 | 2010 | 513 | 0.070 |
Why?
|
| Insulin-Secreting Cells | 1 | 2013 | 907 | 0.070 |
Why?
|
| Protein Interaction Mapping | 1 | 2009 | 617 | 0.070 |
Why?
|
| Heart Transplantation | 1 | 2019 | 3217 | 0.070 |
Why?
|
| Inflammation | 6 | 2023 | 10757 | 0.070 |
Why?
|
| Jurkat Cells | 2 | 1998 | 736 | 0.060 |
Why?
|
| Pyruvic Acid | 2 | 2022 | 195 | 0.060 |
Why?
|
| Swine | 3 | 2023 | 5902 | 0.060 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 2 | 2012 | 4573 | 0.060 |
Why?
|
| Citric Acid | 1 | 2005 | 123 | 0.060 |
Why?
|
| Fibronectins | 1 | 2009 | 721 | 0.060 |
Why?
|
| Lethal Dose 50 | 2 | 2017 | 72 | 0.060 |
Why?
|
| Alleles | 2 | 2015 | 6900 | 0.060 |
Why?
|
| Matrix Metalloproteinase 2 | 1 | 2007 | 462 | 0.060 |
Why?
|
| Receptors, CXCR3 | 1 | 2006 | 238 | 0.060 |
Why?
|
| Transcription Factors | 4 | 2023 | 12100 | 0.060 |
Why?
|
| Pluripotent Stem Cells | 1 | 2012 | 791 | 0.060 |
Why?
|
| Reference Standards | 1 | 2008 | 1004 | 0.060 |
Why?
|
| Pregnancy | 3 | 2015 | 29725 | 0.060 |
Why?
|
| Cardiomyopathies | 1 | 2016 | 1945 | 0.060 |
Why?
|
| Sulfones | 1 | 2007 | 447 | 0.060 |
Why?
|
| Causality | 1 | 2011 | 1241 | 0.060 |
Why?
|
| Health Surveys | 1 | 2015 | 4061 | 0.060 |
Why?
|
| Ticlopidine | 1 | 2010 | 895 | 0.060 |
Why?
|
| Metagenomics | 2 | 2020 | 457 | 0.060 |
Why?
|
| Waist Circumference | 2 | 2022 | 922 | 0.060 |
Why?
|
| China | 2 | 2022 | 2340 | 0.060 |
Why?
|
| Aorta, Abdominal | 1 | 2007 | 622 | 0.060 |
Why?
|
| Phosphorylation | 3 | 2021 | 8314 | 0.060 |
Why?
|
| Transfection | 3 | 2015 | 5782 | 0.060 |
Why?
|
| Insulin Receptor Substrate Proteins | 2 | 2019 | 557 | 0.060 |
Why?
|
| Growth Differentiation Factor 15 | 2 | 2016 | 192 | 0.060 |
Why?
|
| Glycine | 2 | 2018 | 663 | 0.060 |
Why?
|
| Prevalence | 2 | 2024 | 15687 | 0.060 |
Why?
|
| Dose-Response Relationship, Drug | 3 | 2015 | 10829 | 0.060 |
Why?
|
| Matrix Metalloproteinase 9 | 1 | 2007 | 633 | 0.060 |
Why?
|
| Chi-Square Distribution | 3 | 2017 | 3466 | 0.060 |
Why?
|
| Galectin 3 | 2 | 2016 | 240 | 0.060 |
Why?
|
| Antigens, Ly | 1 | 2005 | 293 | 0.060 |
Why?
|
| RNA Interference | 2 | 2010 | 2846 | 0.060 |
Why?
|
| Chemokine CCL5 | 1 | 2004 | 214 | 0.060 |
Why?
|
| Chemokine CXCL12 | 1 | 2005 | 454 | 0.060 |
Why?
|
| Biomedical Research | 2 | 2016 | 3421 | 0.060 |
Why?
|
| Forkhead Transcription Factors | 2 | 2013 | 1613 | 0.060 |
Why?
|
| Ketones | 2 | 2019 | 183 | 0.060 |
Why?
|
| Adenosine Monophosphate | 1 | 2005 | 283 | 0.060 |
Why?
|
| Weight Gain | 1 | 2014 | 2347 | 0.050 |
Why?
|
| Lipoprotein Lipase | 1 | 2023 | 134 | 0.050 |
Why?
|
| Matrix Metalloproteinase 12 | 1 | 2023 | 44 | 0.050 |
Why?
|
| Cardiolipins | 1 | 2023 | 81 | 0.050 |
Why?
|
| PPAR gamma | 2 | 2019 | 484 | 0.050 |
Why?
|
| False Negative Reactions | 1 | 2004 | 574 | 0.050 |
Why?
|
| Carcinoma, Pancreatic Ductal | 1 | 2014 | 1720 | 0.050 |
Why?
|
| Mitochondrial Membrane Transport Proteins | 1 | 2024 | 159 | 0.050 |
Why?
|
| Glucuronates | 1 | 2022 | 40 | 0.050 |
Why?
|
| Mesenteric Arteries | 1 | 2003 | 178 | 0.050 |
Why?
|
| Hepatocytes | 2 | 2022 | 1228 | 0.050 |
Why?
|
| Hemopexin | 1 | 2022 | 32 | 0.050 |
Why?
|
| Oxidative Stress | 2 | 2024 | 3107 | 0.050 |
Why?
|
| Ovarian Neoplasms | 1 | 2020 | 4875 | 0.050 |
Why?
|
| Adenosine Triphosphate | 2 | 2020 | 1995 | 0.050 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 2 | 2003 | 1746 | 0.050 |
Why?
|
| Chemotactic Factors | 1 | 2003 | 196 | 0.050 |
Why?
|
| Mice, Mutant Strains | 1 | 2006 | 1760 | 0.050 |
Why?
|
| Acute Coronary Syndrome | 1 | 2016 | 2362 | 0.050 |
Why?
|
| Ligands | 3 | 2019 | 3277 | 0.050 |
Why?
|
| Models, Cardiovascular | 1 | 2008 | 974 | 0.050 |
Why?
|
| Tomography, Emission-Computed, Single-Photon | 1 | 2008 | 1067 | 0.050 |
Why?
|
| Alternative Splicing | 1 | 2008 | 1091 | 0.050 |
Why?
|
| Deoxycholic Acid | 1 | 2022 | 53 | 0.050 |
Why?
|
| Ketoglutarate Dehydrogenase Complex | 1 | 2022 | 21 | 0.050 |
Why?
|
| Lysophosphatidylcholines | 1 | 2022 | 77 | 0.050 |
Why?
|
| Receptors, Platelet-Derived Growth Factor | 1 | 2022 | 178 | 0.050 |
Why?
|
| Matrix Metalloproteinase 1 | 1 | 2022 | 142 | 0.050 |
Why?
|
| Reperfusion | 1 | 2023 | 271 | 0.050 |
Why?
|
| Pseudouridine | 1 | 2022 | 19 | 0.050 |
Why?
|
| RNA, Messenger | 2 | 2008 | 12762 | 0.050 |
Why?
|
| Guanosine | 1 | 2022 | 49 | 0.050 |
Why?
|
| CD4-Positive T-Lymphocytes | 2 | 2006 | 4355 | 0.050 |
Why?
|
| Fluorodeoxyglucose F18 | 1 | 2011 | 2007 | 0.050 |
Why?
|
| Cell Movement | 4 | 2011 | 5206 | 0.050 |
Why?
|
| Apolipoproteins B | 1 | 2023 | 388 | 0.050 |
Why?
|
| Hemodynamics | 2 | 2023 | 4169 | 0.050 |
Why?
|
| Systole | 2 | 2019 | 947 | 0.050 |
Why?
|
| Apolipoproteins | 1 | 2024 | 320 | 0.050 |
Why?
|
| False Positive Reactions | 1 | 2004 | 956 | 0.050 |
Why?
|
| Psychomotor Performance | 1 | 2010 | 1876 | 0.050 |
Why?
|
| Tumor Suppressor Proteins | 1 | 2012 | 2804 | 0.050 |
Why?
|
| Dipeptides | 1 | 2024 | 410 | 0.050 |
Why?
|
| Serine | 1 | 2005 | 831 | 0.050 |
Why?
|
| Glycerol | 1 | 2022 | 277 | 0.050 |
Why?
|
| Plasminogen Activator Inhibitor 1 | 1 | 2022 | 280 | 0.050 |
Why?
|
| Lipase | 1 | 2023 | 324 | 0.050 |
Why?
|
| Sulfonic Acids | 1 | 2021 | 102 | 0.050 |
Why?
|
| Acyltransferases | 1 | 2023 | 306 | 0.050 |
Why?
|
| Magnetic Resonance Spectroscopy | 1 | 2011 | 3764 | 0.050 |
Why?
|
| Fish Products | 1 | 2021 | 29 | 0.050 |
Why?
|
| Protein Binding | 5 | 2009 | 9336 | 0.050 |
Why?
|
| Glutamates | 1 | 2022 | 391 | 0.050 |
Why?
|
| Hemolysis | 1 | 2023 | 423 | 0.050 |
Why?
|
| High-Throughput Nucleotide Sequencing | 1 | 2013 | 3618 | 0.050 |
Why?
|
| Biology | 1 | 2023 | 289 | 0.050 |
Why?
|
| Lactase | 1 | 2021 | 71 | 0.050 |
Why?
|
| Mississippi | 1 | 2021 | 93 | 0.050 |
Why?
|
| Pandemics | 1 | 2021 | 8621 | 0.050 |
Why?
|
| Proto-Oncogene Proteins c-kit | 1 | 2005 | 729 | 0.050 |
Why?
|
| Radiopharmaceuticals | 1 | 2011 | 2633 | 0.050 |
Why?
|
| Cell Survival | 2 | 2016 | 5796 | 0.050 |
Why?
|
| Thrombolytic Therapy | 1 | 2010 | 2108 | 0.050 |
Why?
|
| Phosphatidylcholines | 1 | 2022 | 406 | 0.050 |
Why?
|
| Sweden | 1 | 2024 | 1381 | 0.050 |
Why?
|
| Molecular Probes | 1 | 2002 | 313 | 0.050 |
Why?
|
| Nitric Oxide Synthase | 1 | 2004 | 908 | 0.050 |
Why?
|
| Toll-Like Receptors | 1 | 2004 | 590 | 0.050 |
Why?
|
| Peptides | 4 | 2009 | 4358 | 0.050 |
Why?
|
| Rhinovirus | 1 | 2022 | 202 | 0.050 |
Why?
|
| Meat Products | 1 | 2021 | 96 | 0.050 |
Why?
|
| Angiopoietin-2 | 1 | 2021 | 173 | 0.050 |
Why?
|
| Cytochrome P-450 CYP2D6 | 1 | 2021 | 105 | 0.050 |
Why?
|
| Oxidants | 1 | 2021 | 169 | 0.050 |
Why?
|
| Disease Progression | 3 | 2016 | 13505 | 0.050 |
Why?
|
| Plaque, Atherosclerotic | 1 | 2012 | 1520 | 0.050 |
Why?
|
| Interleukin-10 | 1 | 2006 | 1174 | 0.050 |
Why?
|
| Vital Capacity | 1 | 2023 | 965 | 0.040 |
Why?
|
| Glioblastoma | 1 | 2015 | 3482 | 0.040 |
Why?
|
| Interleukin-13 | 1 | 2022 | 371 | 0.040 |
Why?
|
| Spectroscopy, Near-Infrared | 2 | 2002 | 740 | 0.040 |
Why?
|
| Ischemic Preconditioning | 1 | 2021 | 89 | 0.040 |
Why?
|
| Population Density | 1 | 2021 | 192 | 0.040 |
Why?
|
| Mice, SCID | 2 | 2015 | 2627 | 0.040 |
Why?
|
| Colorectal Neoplasms | 1 | 2020 | 6855 | 0.040 |
Why?
|
| Spirometry | 1 | 2023 | 924 | 0.040 |
Why?
|
| P-Selectin | 2 | 2004 | 600 | 0.040 |
Why?
|
| rhoA GTP-Binding Protein | 1 | 2001 | 235 | 0.040 |
Why?
|
| Phosphorylcholine | 1 | 2020 | 153 | 0.040 |
Why?
|
| Endotoxemia | 1 | 2021 | 196 | 0.040 |
Why?
|
| Dipeptidases | 1 | 2019 | 38 | 0.040 |
Why?
|
| Receptors, Lysophosphatidic Acid | 1 | 2020 | 77 | 0.040 |
Why?
|
| CD4 Lymphocyte Count | 1 | 2006 | 2569 | 0.040 |
Why?
|
| MAP Kinase Kinase Kinase 1 | 1 | 2019 | 56 | 0.040 |
Why?
|
| INDEL Mutation | 1 | 2021 | 266 | 0.040 |
Why?
|
| Ventricular Dysfunction, Left | 1 | 2011 | 2129 | 0.040 |
Why?
|
| Cell Membrane | 4 | 2004 | 3683 | 0.040 |
Why?
|
| Carnitine O-Palmitoyltransferase | 1 | 2019 | 83 | 0.040 |
Why?
|
| Muscle Strength | 1 | 2024 | 619 | 0.040 |
Why?
|
| Hand Strength | 1 | 2022 | 452 | 0.040 |
Why?
|
| Dinoprostone | 1 | 2022 | 599 | 0.040 |
Why?
|
| Lipoproteins, HDL | 1 | 2024 | 667 | 0.040 |
Why?
|
| Receptors, Leukocyte-Adhesion | 1 | 1999 | 52 | 0.040 |
Why?
|
| Taxoids | 2 | 2013 | 668 | 0.040 |
Why?
|
| Autoantibodies | 1 | 2008 | 2119 | 0.040 |
Why?
|
| Botulinum Toxins | 1 | 2001 | 188 | 0.040 |
Why?
|
| Reactive Oxygen Species | 2 | 2024 | 2138 | 0.040 |
Why?
|
| Animals, Genetically Modified | 1 | 2004 | 1553 | 0.040 |
Why?
|
| Mitochondria, Heart | 1 | 2021 | 229 | 0.040 |
Why?
|
| Mesenchymal Stem Cell Transplantation | 2 | 2017 | 498 | 0.040 |
Why?
|
| Immunoglobulin E | 2 | 2022 | 1493 | 0.040 |
Why?
|
| Aminoimidazole Carboxamide | 1 | 2019 | 85 | 0.040 |
Why?
|
| Ribonucleotides | 1 | 2019 | 114 | 0.040 |
Why?
|
| Cross Reactions | 1 | 2021 | 818 | 0.040 |
Why?
|
| Subcutaneous Fat | 1 | 2022 | 393 | 0.040 |
Why?
|
| Tryptophan | 1 | 2021 | 480 | 0.040 |
Why?
|
| Follistatin-Related Proteins | 1 | 2019 | 48 | 0.040 |
Why?
|
| Mutagenesis | 2 | 2021 | 1234 | 0.040 |
Why?
|
| Sequence Analysis, RNA | 2 | 2017 | 2003 | 0.040 |
Why?
|
| Follistatin | 1 | 2019 | 136 | 0.040 |
Why?
|
| Brachial Artery | 1 | 2020 | 368 | 0.040 |
Why?
|
| Norway | 1 | 2020 | 497 | 0.040 |
Why?
|
| Epidemiologic Studies | 1 | 2022 | 670 | 0.040 |
Why?
|
| Hyperplasia | 1 | 2002 | 1158 | 0.040 |
Why?
|
| Diet Records | 1 | 2020 | 427 | 0.040 |
Why?
|
| Nutritional Sciences | 1 | 2020 | 143 | 0.040 |
Why?
|
| Sarcoplasmic Reticulum Calcium-Transporting ATPases | 1 | 2019 | 128 | 0.040 |
Why?
|
| Hormones | 1 | 2022 | 867 | 0.040 |
Why?
|
| 5'-Nucleotidase | 1 | 2019 | 161 | 0.040 |
Why?
|
| Independent Living | 1 | 2022 | 568 | 0.040 |
Why?
|
| Confidence Intervals | 1 | 2024 | 2932 | 0.040 |
Why?
|
| Transforming Growth Factor beta | 1 | 2006 | 1956 | 0.040 |
Why?
|
| Acceleration | 1 | 2019 | 189 | 0.040 |
Why?
|
| Base Sequence | 2 | 2011 | 12447 | 0.040 |
Why?
|
| Gene Expression Regulation | 2 | 2014 | 11902 | 0.040 |
Why?
|
| Forced Expiratory Volume | 1 | 2023 | 1810 | 0.040 |
Why?
|
| Integrin alpha4 | 1 | 1998 | 87 | 0.040 |
Why?
|
| Quality Control | 1 | 2021 | 827 | 0.040 |
Why?
|
| Introns | 2 | 2011 | 978 | 0.040 |
Why?
|
| Nutritional Physiological Phenomena | 1 | 2020 | 363 | 0.040 |
Why?
|
| Kidney Glomerulus | 1 | 2020 | 568 | 0.040 |
Why?
|
| Cell Division | 2 | 2004 | 4462 | 0.040 |
Why?
|
| GPI-Linked Proteins | 1 | 2019 | 468 | 0.040 |
Why?
|
| C-Reactive Protein | 3 | 2016 | 3822 | 0.040 |
Why?
|
| Receptor, Platelet-Derived Growth Factor beta | 1 | 2018 | 184 | 0.040 |
Why?
|
| Medicare | 3 | 2021 | 6771 | 0.040 |
Why?
|
| L-Selectin | 1 | 1998 | 209 | 0.040 |
Why?
|
| Taurine | 1 | 2018 | 93 | 0.040 |
Why?
|
| Contrast Media | 1 | 2011 | 5301 | 0.040 |
Why?
|
| Sample Size | 1 | 2021 | 840 | 0.040 |
Why?
|
| Structure-Activity Relationship | 3 | 2006 | 3086 | 0.040 |
Why?
|
| Activins | 1 | 2019 | 210 | 0.040 |
Why?
|
| Cytokine Receptor Common beta Subunit | 1 | 2017 | 22 | 0.040 |
Why?
|
| omega-N-Methylarginine | 1 | 2017 | 108 | 0.040 |
Why?
|
| Carbohydrate Metabolism | 1 | 2018 | 262 | 0.040 |
Why?
|
| Sodium | 1 | 2022 | 1601 | 0.040 |
Why?
|
| Drug Evaluation, Preclinical | 2 | 2013 | 1346 | 0.040 |
Why?
|
| Mutation | 4 | 2021 | 29950 | 0.040 |
Why?
|
| Bone Marrow Cells | 1 | 2005 | 2424 | 0.040 |
Why?
|
| Platelet-Derived Growth Factor | 1 | 2019 | 617 | 0.040 |
Why?
|
| Calcium Signaling | 1 | 2021 | 731 | 0.040 |
Why?
|
| Exercise Therapy | 1 | 2024 | 920 | 0.040 |
Why?
|
| Models, Biological | 2 | 2011 | 9468 | 0.040 |
Why?
|
| Platelet Aggregation Inhibitors | 1 | 2010 | 3201 | 0.040 |
Why?
|
| Tumor Necrosis Factor-alpha | 3 | 2022 | 4357 | 0.040 |
Why?
|
| Combined Modality Therapy | 2 | 2021 | 8551 | 0.040 |
Why?
|
| Prostatic Neoplasms | 1 | 2020 | 11341 | 0.040 |
Why?
|
| Lung Neoplasms | 2 | 2020 | 13249 | 0.040 |
Why?
|
| Platelet Aggregation | 1 | 2020 | 805 | 0.030 |
Why?
|
| Pilot Projects | 2 | 2022 | 8553 | 0.030 |
Why?
|
| Piperazines | 1 | 2007 | 2520 | 0.030 |
Why?
|
| Electron Transport Complex IV | 1 | 2017 | 190 | 0.030 |
Why?
|
| Cysteine | 1 | 2021 | 897 | 0.030 |
Why?
|
| Mice, Nude | 2 | 2017 | 3605 | 0.030 |
Why?
|
| Pancreatic Neoplasms | 1 | 2014 | 5333 | 0.030 |
Why?
|
| Polymerase Chain Reaction | 1 | 2006 | 6067 | 0.030 |
Why?
|
| Sulfur | 1 | 2017 | 163 | 0.030 |
Why?
|
| Lymphokines | 1 | 2019 | 929 | 0.030 |
Why?
|
| Amino Acid Sequence | 4 | 2009 | 13456 | 0.030 |
Why?
|
| Blotting, Western | 2 | 2020 | 5039 | 0.030 |
Why?
|
| Membrane Proteins | 2 | 2022 | 7854 | 0.030 |
Why?
|
| Ultrasonography | 1 | 2009 | 5960 | 0.030 |
Why?
|
| Nutrigenomics | 1 | 2016 | 24 | 0.030 |
Why?
|
| Mammals | 1 | 2022 | 1129 | 0.030 |
Why?
|
| Adenoviruses, Human | 1 | 1998 | 255 | 0.030 |
Why?
|
| Molecular Sequence Data | 4 | 2011 | 17628 | 0.030 |
Why?
|
| Glycogen | 1 | 2016 | 251 | 0.030 |
Why?
|
| Vasodilation | 1 | 2020 | 964 | 0.030 |
Why?
|
| Histidine | 1 | 2017 | 311 | 0.030 |
Why?
|
| Adrenomedullin | 1 | 2016 | 85 | 0.030 |
Why?
|
| Aniline Compounds | 1 | 2021 | 1068 | 0.030 |
Why?
|
| Pentosyltransferases | 1 | 2015 | 62 | 0.030 |
Why?
|
| Frail Elderly | 1 | 2021 | 747 | 0.030 |
Why?
|
| Body Fat Distribution | 1 | 2017 | 243 | 0.030 |
Why?
|
| Diet Surveys | 1 | 2020 | 1161 | 0.030 |
Why?
|
| Autoimmune Diseases | 1 | 2008 | 2250 | 0.030 |
Why?
|
| Pregnancy-Associated Plasma Protein-A | 1 | 2016 | 60 | 0.030 |
Why?
|
| Epigenesis, Genetic | 2 | 2022 | 3758 | 0.030 |
Why?
|
| Muscle Cells | 1 | 2016 | 195 | 0.030 |
Why?
|
| Double-Blind Method | 2 | 2021 | 12412 | 0.030 |
Why?
|
| Creatinine | 1 | 2021 | 1906 | 0.030 |
Why?
|
| Pressure | 1 | 2019 | 1155 | 0.030 |
Why?
|
| Superoxide Dismutase | 1 | 2018 | 594 | 0.030 |
Why?
|
| Internationality | 1 | 2021 | 1005 | 0.030 |
Why?
|
| 1-Acylglycerol-3-Phosphate O-Acyltransferase | 1 | 2015 | 9 | 0.030 |
Why?
|
| Vegetables | 1 | 2021 | 1198 | 0.030 |
Why?
|
| Lectins, C-Type | 1 | 2018 | 591 | 0.030 |
Why?
|
| Constriction, Pathologic | 1 | 2019 | 1098 | 0.030 |
Why?
|
| Class I Phosphatidylinositol 3-Kinases | 1 | 2019 | 896 | 0.030 |
Why?
|
| Genome | 1 | 2023 | 1739 | 0.030 |
Why?
|
| Solubility | 1 | 2017 | 1088 | 0.030 |
Why?
|
| Atrial Natriuretic Factor | 1 | 2016 | 350 | 0.030 |
Why?
|
| Bone Morphogenetic Protein 4 | 1 | 2015 | 161 | 0.030 |
Why?
|
| Extremities | 1 | 2020 | 867 | 0.030 |
Why?
|
| Food | 1 | 2020 | 772 | 0.030 |
Why?
|
| Glycopeptides | 1 | 2016 | 220 | 0.030 |
Why?
|
| Indoles | 1 | 2023 | 1830 | 0.030 |
Why?
|
| Chromosomes, Human, Pair 1 | 1 | 2017 | 635 | 0.030 |
Why?
|
| Apoptosis | 2 | 2013 | 9497 | 0.030 |
Why?
|
| Ceramides | 1 | 2016 | 200 | 0.030 |
Why?
|
| Urinalysis | 1 | 2017 | 368 | 0.030 |
Why?
|
| Lymphocyte Activation | 2 | 2022 | 5498 | 0.030 |
Why?
|
| Coronary Vessels | 1 | 2006 | 3112 | 0.030 |
Why?
|
| HEK293 Cells | 2 | 2015 | 4264 | 0.030 |
Why?
|
| Neovascularization, Pathologic | 1 | 2005 | 2641 | 0.030 |
Why?
|
| Haplotypes | 1 | 2021 | 2764 | 0.030 |
Why?
|
| Positron-Emission Tomography | 1 | 2011 | 6457 | 0.030 |
Why?
|
| Enzyme Activation | 2 | 2015 | 3604 | 0.030 |
Why?
|
| Proto-Oncogene Proteins c-sis | 1 | 2015 | 256 | 0.030 |
Why?
|
| Brain Neoplasms | 1 | 2015 | 8984 | 0.030 |
Why?
|
| Dietary Supplements | 2 | 2018 | 3389 | 0.030 |
Why?
|
| Glutarates | 1 | 2015 | 244 | 0.030 |
Why?
|
| Heterozygote | 1 | 2021 | 2797 | 0.030 |
Why?
|
| Spheroids, Cellular | 1 | 2015 | 329 | 0.030 |
Why?
|
| Mesenchymal Stem Cells | 2 | 2017 | 1634 | 0.030 |
Why?
|
| Mice, Inbred DBA | 1 | 2015 | 622 | 0.030 |
Why?
|
| Antibodies, Monoclonal | 1 | 2011 | 9196 | 0.030 |
Why?
|
| Fluorescent Dyes | 1 | 2002 | 1914 | 0.030 |
Why?
|
| Cluster Analysis | 2 | 2012 | 2698 | 0.030 |
Why?
|
| Down-Regulation | 2 | 2017 | 2918 | 0.030 |
Why?
|
| Placebos | 1 | 2018 | 1672 | 0.030 |
Why?
|
| Mice, Inbred C3H | 1 | 2015 | 915 | 0.030 |
Why?
|
| Glipizide | 1 | 2013 | 48 | 0.030 |
Why?
|
| Child of Impaired Parents | 1 | 2017 | 459 | 0.030 |
Why?
|
| Biological Specimen Banks | 1 | 2019 | 776 | 0.030 |
Why?
|
| Glycogen Synthase Kinase 3 | 1 | 2015 | 409 | 0.030 |
Why?
|
| Galectins | 1 | 2016 | 282 | 0.030 |
Why?
|
| Pralidoxime Compounds | 1 | 2012 | 5 | 0.030 |
Why?
|
| Cholinesterase Reactivators | 1 | 2012 | 6 | 0.030 |
Why?
|
| Emetine | 1 | 2012 | 15 | 0.030 |
Why?
|
| Vascular Diseases | 1 | 2021 | 1180 | 0.030 |
Why?
|
| Neoplasms | 2 | 2015 | 22066 | 0.030 |
Why?
|
| Glycopyrrolate | 1 | 2012 | 32 | 0.030 |
Why?
|
| Metoclopramide | 1 | 2012 | 51 | 0.030 |
Why?
|
| Nutrition Assessment | 1 | 2016 | 725 | 0.030 |
Why?
|
| Arrhythmias, Cardiac | 1 | 2022 | 2255 | 0.030 |
Why?
|
| Nitroprusside | 1 | 2013 | 273 | 0.030 |
Why?
|
| Isoleucine | 1 | 2012 | 110 | 0.030 |
Why?
|
| Organometallic Compounds | 2 | 2008 | 659 | 0.030 |
Why?
|
| Neoplasm Transplantation | 2 | 2008 | 2014 | 0.030 |
Why?
|
| Neostigmine | 1 | 2012 | 68 | 0.030 |
Why?
|
| Mice, Inbred Strains | 1 | 2015 | 1765 | 0.030 |
Why?
|
| Genetic Vectors | 2 | 2002 | 3378 | 0.030 |
Why?
|
| Proteasome Endopeptidase Complex | 1 | 2019 | 1314 | 0.030 |
Why?
|
| Interleukin-6 | 1 | 2022 | 3207 | 0.030 |
Why?
|
| Lysine | 1 | 2017 | 1002 | 0.030 |
Why?
|
| Rats, Sprague-Dawley | 1 | 2003 | 8157 | 0.030 |
Why?
|
| Pirenzepine | 1 | 2012 | 116 | 0.030 |
Why?
|
| Atropine | 1 | 2012 | 245 | 0.030 |
Why?
|
| Microscopy, Fluorescence | 3 | 2005 | 2651 | 0.030 |
Why?
|
| Xenopus | 1 | 1994 | 717 | 0.020 |
Why?
|
| Glomerular Filtration Rate | 1 | 2020 | 2178 | 0.020 |
Why?
|
| Protein Precursors | 1 | 2016 | 1135 | 0.020 |
Why?
|
| Vascular Endothelial Growth Factor Receptor-1 | 1 | 2015 | 558 | 0.020 |
Why?
|
| Sirolimus | 1 | 2019 | 1548 | 0.020 |
Why?
|
| CCAAT-Enhancer-Binding Protein-beta | 1 | 2012 | 102 | 0.020 |
Why?
|
| Cholinergic Antagonists | 1 | 2012 | 164 | 0.020 |
Why?
|
| Coculture Techniques | 1 | 2015 | 1340 | 0.020 |
Why?
|
| Troponin C | 1 | 2011 | 24 | 0.020 |
Why?
|
| Absorptiometry, Photon | 1 | 2017 | 1731 | 0.020 |
Why?
|
| Spectrum Analysis | 1 | 2013 | 453 | 0.020 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 1 | 2021 | 2874 | 0.020 |
Why?
|
| Bone Density | 1 | 2024 | 3528 | 0.020 |
Why?
|
| Primates | 1 | 2013 | 523 | 0.020 |
Why?
|
| Mice, Inbred NOD | 1 | 2015 | 1837 | 0.020 |
Why?
|
| Valine | 1 | 2012 | 409 | 0.020 |
Why?
|
| Internet | 1 | 2023 | 3074 | 0.020 |
Why?
|
| Gene Knockdown Techniques | 1 | 2015 | 1617 | 0.020 |
Why?
|
| Computer Simulation | 1 | 2024 | 6210 | 0.020 |
Why?
|
| Manometry | 1 | 2013 | 453 | 0.020 |
Why?
|
| Prekallikrein | 1 | 2009 | 11 | 0.020 |
Why?
|
| GABA Plasma Membrane Transport Proteins | 1 | 2010 | 29 | 0.020 |
Why?
|
| Chromatin | 1 | 2022 | 2939 | 0.020 |
Why?
|
| Bacteria | 1 | 2021 | 2196 | 0.020 |
Why?
|
| 3T3 Cells | 1 | 2012 | 1085 | 0.020 |
Why?
|
| Sterol Regulatory Element Binding Protein 2 | 1 | 2010 | 56 | 0.020 |
Why?
|
| Amino Acid Transport Systems | 1 | 2010 | 35 | 0.020 |
Why?
|
| Autoradiography | 1 | 2011 | 730 | 0.020 |
Why?
|
| Tissue Distribution | 2 | 2005 | 2262 | 0.020 |
Why?
|
| Workflow | 1 | 2015 | 851 | 0.020 |
Why?
|
| Glucose Metabolism Disorders | 1 | 2010 | 52 | 0.020 |
Why?
|
| Dietary Carbohydrates | 1 | 2015 | 893 | 0.020 |
Why?
|
| Diabetic Nephropathies | 1 | 2017 | 988 | 0.020 |
Why?
|
| Drug Approval | 1 | 2017 | 816 | 0.020 |
Why?
|
| Sterol Regulatory Element Binding Protein 1 | 1 | 2010 | 135 | 0.020 |
Why?
|
| Sampling Studies | 1 | 2011 | 614 | 0.020 |
Why?
|
| Sequence Homology, Amino Acid | 1 | 1994 | 2755 | 0.020 |
Why?
|
| Retrospective Studies | 5 | 2021 | 80301 | 0.020 |
Why?
|
| Biopsy | 1 | 2021 | 6775 | 0.020 |
Why?
|
| Europe | 1 | 2016 | 3433 | 0.020 |
Why?
|
| Legionellosis | 1 | 1989 | 11 | 0.020 |
Why?
|
| Systems Integration | 1 | 2011 | 426 | 0.020 |
Why?
|
| Necrosis | 1 | 2013 | 1612 | 0.020 |
Why?
|
| Mortality | 1 | 2020 | 2916 | 0.020 |
Why?
|
| Health Behavior | 1 | 2021 | 2621 | 0.020 |
Why?
|
| Pyridines | 1 | 2001 | 2877 | 0.020 |
Why?
|
| Splenectomy | 1 | 2011 | 391 | 0.020 |
Why?
|
| Oxygen | 1 | 2021 | 4189 | 0.020 |
Why?
|
| Survival Analysis | 2 | 2015 | 10185 | 0.020 |
Why?
|
| Intracellular Space | 1 | 2010 | 197 | 0.020 |
Why?
|
| Glutamine | 1 | 2012 | 576 | 0.020 |
Why?
|
| Sirtuins | 1 | 2011 | 320 | 0.020 |
Why?
|
| Recombinant Fusion Proteins | 2 | 1995 | 3735 | 0.020 |
Why?
|
| Academic Medical Centers | 1 | 2019 | 2753 | 0.020 |
Why?
|
| North America | 1 | 2012 | 1282 | 0.020 |
Why?
|
| Fructosediphosphates | 1 | 2008 | 24 | 0.020 |
Why?
|
| Polymorphism, Genetic | 1 | 2019 | 4286 | 0.020 |
Why?
|
| Conserved Sequence | 1 | 2011 | 1168 | 0.020 |
Why?
|
| Diagnostic Imaging | 1 | 2002 | 3526 | 0.020 |
Why?
|
| Research Design | 1 | 2024 | 6181 | 0.020 |
Why?
|
| Extracellular Space | 1 | 2010 | 565 | 0.020 |
Why?
|
| Tumor Cells, Cultured | 1 | 2015 | 6131 | 0.020 |
Why?
|
| Cell Line, Tumor | 3 | 2012 | 16905 | 0.020 |
Why?
|
| 3' Untranslated Regions | 1 | 2010 | 514 | 0.020 |
Why?
|
| Brain | 2 | 2023 | 26912 | 0.020 |
Why?
|
| Water Supply | 1 | 1989 | 208 | 0.020 |
Why?
|
| Cardiomyopathy, Dilated | 1 | 2013 | 819 | 0.020 |
Why?
|
| Autophagy | 1 | 2015 | 1336 | 0.020 |
Why?
|
| Early Diagnosis | 1 | 2012 | 1181 | 0.020 |
Why?
|
| Severity of Illness Index | 2 | 2019 | 15827 | 0.020 |
Why?
|
| Antigens, CD | 1 | 1998 | 4002 | 0.020 |
Why?
|
| Mutation, Missense | 1 | 2016 | 2563 | 0.020 |
Why?
|
| Tissue Donors | 1 | 2017 | 2314 | 0.020 |
Why?
|
| Host-Pathogen Interactions | 1 | 2016 | 1447 | 0.020 |
Why?
|
| Oligonucleotides, Antisense | 1 | 2010 | 459 | 0.020 |
Why?
|
| Xenograft Model Antitumor Assays | 1 | 2015 | 3584 | 0.020 |
Why?
|
| Tachycardia, Ventricular | 1 | 1996 | 1302 | 0.020 |
Why?
|
| Principal Component Analysis | 1 | 2010 | 939 | 0.020 |
Why?
|
| Actins | 2 | 2006 | 2049 | 0.020 |
Why?
|
| Heart Ventricles | 1 | 2019 | 3811 | 0.020 |
Why?
|
| Phosphodiesterase 5 Inhibitors | 1 | 2007 | 103 | 0.020 |
Why?
|
| Proto-Oncogene Proteins p21(ras) | 1 | 2014 | 1729 | 0.020 |
Why?
|
| Tissue Engineering | 1 | 2016 | 1867 | 0.020 |
Why?
|
| Cell Proliferation | 2 | 2015 | 10434 | 0.020 |
Why?
|
| Intercellular Junctions | 1 | 2006 | 197 | 0.020 |
Why?
|
| Breast | 1 | 2015 | 1980 | 0.020 |
Why?
|
| Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2001 | 3333 | 0.020 |
Why?
|
| Cognition | 1 | 2023 | 6948 | 0.020 |
Why?
|
| Proto-Oncogene Proteins | 1 | 2018 | 4494 | 0.020 |
Why?
|
| Carcinoma, Hepatocellular | 1 | 2018 | 2297 | 0.020 |
Why?
|
| Oxidative Phosphorylation | 1 | 2008 | 495 | 0.020 |
Why?
|
| Disease Susceptibility | 1 | 2012 | 1791 | 0.020 |
Why?
|
| Quality of Life | 1 | 2007 | 13300 | 0.020 |
Why?
|
| Chromatography | 1 | 2005 | 189 | 0.020 |
Why?
|
| Basement Membrane | 1 | 2006 | 348 | 0.020 |
Why?
|
| Peptide Hydrolases | 1 | 2008 | 623 | 0.020 |
Why?
|
| Adoptive Transfer | 1 | 2008 | 825 | 0.020 |
Why?
|
| Colon | 1 | 2013 | 1788 | 0.020 |
Why?
|
| Carcinoma, Lewis Lung | 1 | 2005 | 107 | 0.020 |
Why?
|
| Protein Sorting Signals | 1 | 2005 | 279 | 0.010 |
Why?
|
| Trypsin | 1 | 2005 | 496 | 0.010 |
Why?
|
| Stem Cells | 2 | 2009 | 3525 | 0.010 |
Why?
|
| Fluorescent Antibody Technique, Indirect | 1 | 2005 | 426 | 0.010 |
Why?
|
| Vascular Endothelial Growth Factor A | 1 | 2015 | 3483 | 0.010 |
Why?
|
| Neurons | 1 | 2023 | 9416 | 0.010 |
Why?
|
| Molecular Targeted Therapy | 1 | 2015 | 2805 | 0.010 |
Why?
|
| Gene Expression Regulation, Developmental | 1 | 2015 | 3601 | 0.010 |
Why?
|
| Recurrence | 1 | 2016 | 8487 | 0.010 |
Why?
|
| Algorithms | 1 | 2024 | 13967 | 0.010 |
Why?
|
| Transplantation, Heterologous | 1 | 2012 | 2378 | 0.010 |
Why?
|
| Lectins | 1 | 2005 | 485 | 0.010 |
Why?
|
| Databases, Protein | 1 | 2005 | 388 | 0.010 |
Why?
|
| Magnetic Resonance Imaging | 2 | 2023 | 36247 | 0.010 |
Why?
|
| Stress, Mechanical | 1 | 2008 | 1666 | 0.010 |
Why?
|
| Liver Neoplasms | 1 | 2018 | 4317 | 0.010 |
Why?
|
| Nitric Oxide Synthase Type II | 1 | 2004 | 514 | 0.010 |
Why?
|
| Green Fluorescent Proteins | 1 | 2008 | 2056 | 0.010 |
Why?
|
| Cytoplasm | 1 | 2006 | 1518 | 0.010 |
Why?
|
| Cytoskeleton | 1 | 2006 | 1167 | 0.010 |
Why?
|
| Pipecolic Acids | 1 | 2002 | 78 | 0.010 |
Why?
|
| Blotting, Northern | 1 | 2003 | 1544 | 0.010 |
Why?
|
| ADP Ribose Transferases | 1 | 2001 | 90 | 0.010 |
Why?
|
| Bronchoalveolar Lavage Fluid | 1 | 2003 | 750 | 0.010 |
Why?
|
| U937 Cells | 1 | 2001 | 262 | 0.010 |
Why?
|
| Models, Molecular | 2 | 2005 | 5429 | 0.010 |
Why?
|
| Nitric Oxide Synthase Type III | 1 | 2004 | 704 | 0.010 |
Why?
|
| Analysis of Variance | 1 | 2009 | 6242 | 0.010 |
Why?
|
| Proteinuria | 1 | 2003 | 594 | 0.010 |
Why?
|
| Interleukin-1 | 1 | 2004 | 1250 | 0.010 |
Why?
|
| Infant | 1 | 2022 | 36030 | 0.010 |
Why?
|
| Microscopy, Electron | 1 | 2003 | 2558 | 0.010 |
Why?
|
| Cross Infection | 1 | 1989 | 1434 | 0.010 |
Why?
|
| Spectrometry, Fluorescence | 1 | 2002 | 686 | 0.010 |
Why?
|
| Phagocytosis | 1 | 2005 | 1536 | 0.010 |
Why?
|
| Blood Coagulation | 1 | 2005 | 1156 | 0.010 |
Why?
|
| Clinical Trials as Topic | 1 | 2015 | 8058 | 0.010 |
Why?
|
| Perfusion | 1 | 2004 | 1376 | 0.010 |
Why?
|
| Protein Kinase Inhibitors | 1 | 2015 | 5640 | 0.010 |
Why?
|
| Homozygote | 1 | 2003 | 1786 | 0.010 |
Why?
|
| Recombination, Genetic | 1 | 2003 | 1526 | 0.010 |
Why?
|
| Protein Processing, Post-Translational | 1 | 2005 | 1977 | 0.010 |
Why?
|
| Pneumonia | 1 | 1989 | 2138 | 0.010 |
Why?
|
| Exons | 1 | 2003 | 2391 | 0.010 |
Why?
|
| Bone Marrow Transplantation | 1 | 2005 | 2696 | 0.010 |
Why?
|
| Integrins | 1 | 2001 | 840 | 0.010 |
Why?
|
| Carrier Proteins | 1 | 2010 | 4938 | 0.010 |
Why?
|
| Coronary Angiography | 1 | 2008 | 4560 | 0.010 |
Why?
|
| Survival Rate | 1 | 2010 | 12806 | 0.010 |
Why?
|
| Heart Rate | 1 | 2007 | 4169 | 0.010 |
Why?
|
| Protein Transport | 1 | 2001 | 1966 | 0.010 |
Why?
|
| Hospitals | 1 | 1989 | 3929 | 0.010 |
Why?
|
| T-Lymphocyte Subsets | 1 | 2003 | 1811 | 0.010 |
Why?
|
| Lymphocytes | 1 | 2003 | 2612 | 0.010 |
Why?
|
| Bone Marrow | 1 | 2005 | 2918 | 0.010 |
Why?
|
| DNA-Binding Proteins | 1 | 2012 | 9590 | 0.010 |
Why?
|
| Child, Preschool | 1 | 2017 | 42034 | 0.010 |
Why?
|
| Polymers | 1 | 2001 | 1620 | 0.010 |
Why?
|
| Mice, Inbred BALB C | 1 | 2002 | 6226 | 0.010 |
Why?
|
| Carcinoma | 1 | 2005 | 2334 | 0.010 |
Why?
|
| NF-kappa B | 1 | 2002 | 2486 | 0.010 |
Why?
|
| Anti-Arrhythmia Agents | 1 | 1996 | 784 | 0.010 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 2008 | 8498 | 0.010 |
Why?
|
| DNA | 1 | 2005 | 7236 | 0.010 |
Why?
|
| Immunoglobulin G | 1 | 2003 | 4546 | 0.010 |
Why?
|
| Substrate Specificity | 1 | 1995 | 1792 | 0.010 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2008 | 10340 | 0.010 |
Why?
|
| Hospital Bed Capacity, 500 and over | 1 | 1989 | 114 | 0.010 |
Why?
|
| Virginia | 1 | 1989 | 116 | 0.010 |
Why?
|
| Water Microbiology | 1 | 1989 | 115 | 0.000 |
Why?
|
| DNA Mutational Analysis | 1 | 1995 | 4109 | 0.000 |
Why?
|
| Defibrillators, Implantable | 1 | 1996 | 1499 | 0.000 |
Why?
|
| Environmental Monitoring | 1 | 1989 | 1441 | 0.000 |
Why?
|
| Disease Outbreaks | 1 | 1989 | 1759 | 0.000 |
Why?
|